| Type | Description |
|---|---|
| Definition | MAGE family member A1 |
| Date | Results | Publications |
|---|---|---|
| 2020-06-27 11:53:00 | These data suggest that MAGE-A1 is a promising candidate marker for lung adenocarcinoma (LUAD) therapy and the MAGE-A1-specific CAR-T cell immunotherapy may be an effective strategy for the treatment of MAGE-A1-positive LUAD. | 31640756 |
| 2020-05-16 11:51:00 | MAGE-A1 was found in several lung cancer patients | 30569450 |
| 2019-12-14 10:54:00 | Tumor suppressive miR-6775-3p inhibits esophageal squamous cell carcinoma progression through forming a positive feedback loop with p53 via MAGE-A family proteins. | 30333480 |
| 2019-04-27 11:07:00 | GPC3, MAGE1 and 3 were increased with advanced tumor stage, size, and nodule numbers in Hepatocellular Carcinoma | 29708315 |
| 2018-12-22 11:01:00 | The expression of MAGE-A genes in peripheral blood may act as a poor prognostic marker in patients with lung cancer. | 29430849 |
| Type | IDs |
|---|---|
| Synonymous | CT1.1, MAGE1 |
| Gene |
UniProtKB-ID:
MAGA1_HUMAN
UniprotKB:
P43355
UniParc:
UPI0000035FCB
EMBL:
AY148486,
BT009789,
M77481,
CH471172,
BC017555,
AK314979,
U82670
Ensembl:
ENSG00000198681
KO:
hsa:4100
|
| Nucleutide sequences |
EMBL-CDS:
AAP88791.1,
AAH17555.1,
AAA03229.1,
EAW72885.1,
BAG37478.1,
AAN62752.1
Ensembl_TRS:
ENST00000356661
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000349085
RefSeq:
NP_004979.3
|
| Others |
UniRef100:
UniRef100_P43355
UniRef90:
UniRef90_P43355
UniRef50:
UniRef50_P43356
UniGene:
Hs.72879
CCDS:
CCDS76051.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员